Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1966934 | 1.00 | MAPT (0.52) | MAPTCYP3A4KMT2ACYP26A1MEN1 | |
| SCHEMBL2027521 | 0.81 | MEN1 (0.47) | MAPTKMT2AMEN1TDP1HSP90AA1 | |
| SCHEMBL1963863 | 0.81 | MEN1 (0.47) | MAPTKMT2AMEN1TDP1HSP90AA1 | |
| SCHEMBL2181537 | 0.74 | MAPT (0.48) | MAPTCYP3A4KMT2ACYP26A1CYP1A2 | |
| SCHEMBL1938264 | 0.74 | MAPT (0.48) | MAPTCYP3A4KMT2ACYP26A1CYP1A2 | |
| SCHEMBL10666518 | 0.73 | MAPT (0.53) | MAPTCYP3A4KMT2ACYP26A1MEN1 | |
| SCHEMBL10666511 | 0.73 | MAPT (0.53) | MAPTCYP3A4KMT2ACYP26A1MEN1 | |
| SCHEMBL10666615 | 0.71 | MAPT (0.55) | MAPTCYP3A4KMT2AMEN1TDP1 | |
| SCHEMBL2021950 | 0.71 | MAPT (0.47) | MAPTCYP3A4KMT2AMEN1TDP1 | |
| SCHEMBL1966187 | 0.71 | MAPT (0.47) | MAPTCYP3A4KMT2AMEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110160055-A1 | Imidazole and Triazole Compounds as Fungicides | BASF SE (DE) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160055-A1 | Imidazole and Triazole Compounds as Fungicides | CYP51A1, CYP3A43, CYP3A5 | MAPT 1207/4885CYP3A4 9/4885KMT2A 2005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.